biotech

Biosite Inc Obtains Exclusive License for Caspase-1

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on August 26, 2005

BlogPicture

Biosite Incorporated signed an exclusive license with Johannes Gutenberg University, Mainz, Germany for Caspase-1, a potentially important cardiovascular disease biomarker.

The financial terms of the agreement were not disclosed.

Read press release here.

Permalink: Biosite Inc Obtains Exclusive License for Caspase-1

Tags: caspase  cardiovascular  biotech  obtains  exclusive  obtains+exclusive  exclusive+license  biosite+obtains 

Vote for Biosite Inc Obtains Exclusive License for Caspase-1:

  • Currently 6.67/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.67 out of 3 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Tagcloud
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells